LSO Knowledge and Networking Breakfast

HEALTH SYSTEM READINESS IN THE ERA OF CELL AND GENE THERAPY — FROM BENCHTOP TO BEDSIDE

Cell and gene therapies are reshaping the future of medicine, offering transformative possibilities for patients while introducing new challenges for health systems, regulators, and innovators. As these advanced therapies move closer to clinical implementation, Canada must strengthen its readiness across the full innovation pipeline.

This discussion will focus on the adoption of cell and gene therapies within the health system and explore the path from discovery to delivery, including the commercialization challenges of scaling therapies from benchtop to clinic, emerging innovations such as antibody–drug conjugates and personalized medicine, and the evolving Canadian investment landscape supporting the growth of advanced therapies.

Our Speakers:

• Moderator: Cate Murray, President & CEO, Stem Cell Network
• Matthew Campea, Scientific Inside Sales Specialist, Cytiva Nanomedicines
• Heather Cole, Senior Manager, Cancer Clinical Research Unit
• ​Sang Mi Lee, Chief Strategy Officer, MORSE Consulting
• Trevor Reichmann, Associate Professor, University of Toronto & General Surgeon, UHN

Join us for our April LSO Knowledge & Networking Breakfast, bringing together leaders from across the life sciences ecosystem to discuss the future of advanced therapies in Canada.

Date: Thursday, April 16, 2026
Time: 8:00 AM – 10:00 AM
Venue: Fasken Office, 333 Bay St., Suite 2400, Toronto, ON

SEATS ARE LIMITED — REGISTER EARLY TO SECURE YOUR SPOT